Related Experiment Video
Updated: Jul 11, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
[The possibilities of Mexidol usage in neuropediatrics]
N N Zavadenko1, N Yu Suvorinova1, A N Zavadenko1
1Pirogov Russian National Research Medical University, Moscow, Russia.
Insights
Mexidol (ethylmethylhydroxypyridine succinate) shows promise in treating pediatric neurological conditions like ADHD and developmental delays. Further clinical trials are recommended to explore its full potential in neuropediatrics.
Area of Science:
- Neurology
- Pharmacology
- Pediatrics
Context:
- Mexidol (ethylmethylhydroxypyridine succinate) is a neurometabolic drug gaining traction in pediatric neurology.
- Its efficacy has been observed in conditions such as ADHD, hypoxic-ischemic encephalopathy, and post-neurosurgical neurodevelopmental delays.
Purpose:
- To review the current applications and potential of Mexidol in neuropediatrics.
- To highlight the need for further clinical trials based on evidence-based medicine principles.
Summary:
- Mexidol demonstrates positive therapeutic effects in children with various neurological and neurodevelopmental disorders.
- These include attention deficit hyperactivity disorder (ADHD), perinatal central nervous system damage, and neurodevelopmental issues post-congenital heart defect surgery.
- Its multimodal action supports its use in neuroinfections and post-traumatic epilepsy.
Impact:
- Mexidol offers a promising therapeutic option for a range of pediatric neurological conditions.
- Expanding its indications through rigorous clinical trials could significantly benefit neuropediatric patient care.
Abstract:
Mexidol (ethylmethylhydroxypyridine succinate) is a modern neurometabolic medication increasingly being used in neuropediatrics. The results of recent studies confirming the positive effects of Mexidol pharmacotherapy in children with attention deficit hyperactivity disorder (ADHD), perinatal damages of the central nervous system (hypoxic-ischemic encephalopathy) and their consequences, neurological disorders and neurodevelopmental delay after surgery for congenital heart defects, neuroinfections (meningitis, encephalitis), posttraumatic epilepsy. Taking into account the unique multimodal action of Mexidol, it seems promising to expand the range of indications for its application in neuropediatrics, based on the results of new clinical trials organized in accordance with modern principles of evidence-based medicine.
More Related Videos
06:38Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
Published on: June 11, 2017
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Delivery: Enteral Route
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Factors Affecting Drug Response: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management